Skip to main content
OSCR logo

OSCR · Oscar Health, Inc. · Metrics

Track OSCR — free
$27.57 -2.27 (-7.61%) At close · Nov 18 Play latest call Q3 2026 earnings call transcript
Market Cap
$8.57B
Shares
310.69M
Volume · Nov 18 7.4M Avg daily vol (3M) 5.28M

OSCR metrics

86 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$27.57
Market cap
$8.57B

Price action

23 metrics
Price change (1W)
-14.1%
Price change (30D)
-15.3%
Price change (3M)
-14.6%
Price change (6M)
+17.7%
Price change (YTD)
+91.9%
Price change (1Y)
+87.4%
Trailing year
Price change (5Y)
+159.1%
52-week high
$35.19
52-week low
$10.85
Change from 52-week high
-21.7%
Change from 52-week low
+154.1%
Annualized volatility
66.1%
Annualized volatility (3M)
52.5%
Implied volatility (30D)
60.4%
IV rank (1Y)
39.4
IV percentile (1Y)
7.0
Beta
1.5
RSI (14D)
36.3
Price vs SMA 50
-13.4%
Price vs SMA 200
+11.8%
Avg volume (3M)
5.28M
Relative volume
1.4
Average dollar volume
$167.86M

Company

3 metrics
Sector
Healthcare
Industry
Healthcare Plans
Shares outstanding
310.69M

Valuation

12 metrics
P / E (TTM)
11.2
Trailing earnings · reciprocal yield 9.0%
PEG ratio
—
EV / revenue
0.1×
reciprocal yield 1,157.5%
EV / EBITDA
1.6×
reciprocal yield 63.9%
EV / EBIT
1.6×
reciprocal yield 62.1%
P / sales
0.5×
reciprocal yield 204.0%
P / book
3.9
reciprocal yield 25.9%
FCF yield
48.4%
TTM · current market cap
Buyback yield
—
P / FCF
2.1
reciprocal yield 48.4%
P / operating cash flow
2.0
reciprocal yield 48.8%
Earnings yield
10.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-11-05

Profitability

9 metrics
Gross margin
—
Operating margin
5.4%
Trailing 12 months
Net margin
4.9%
Gross profit (TTM)
—
Operating profit (TTM)
$936.99M
Net income (TTM)
$855.47M
Trailing 12 months
Diluted EPS (TTM)
$2.47
FCF margin
23.7%
Effective tax rate
5.4%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+72.1%
Year over year
Net income growth YoY
-1,842.5%
Revenue (TTM)
$17.47B
Trailing 12 months
EPS growth YoY
-1,790.0%
Shares change YoY
+33.6%
Year over year · more shares
Revenue CAGR (3Y)
+43.5%
Revenue CAGR (5Y)
+90.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+44.4%
FCF CAGR (5Y)
+38.4%

Quality

14 metrics
Return on equity
38.5%
Return on assets
8.5%
Debt / equity
0.2
Current ratio
1.1
EBITDA (TTM)
$964.46M
Free cash flow (TTM)
$4.14B
Quick ratio
1.1
Interest coverage
68.3
Net debt / EBITDA
-4.2
Return on invested capital
—
Trailing 12 months
Net cash
$4.03B
Latest balance sheet
Cash & equivalents
$4.47B
Total assets
$10.01B
Total debt
$432.41M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$4.18B
Capital expenditures (TTM)
$40.93M
R&D (TTM)
—
SG&A (TTM)
$2.63B
Stock compensation (TTM)
$77.00M
R&D / revenue
—
Stock compensation / revenue
0.4%

Ownership (13F)

9 metrics
13F filers
422
13F filer change QoQ
+13
Institutional ownership
67.2%
Conviction holders (share of 13F filers)
1.7%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+3.6%
Holder tenure
12.2
Price vs estimated holder cost
+63.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
12.9%

Short interest

3 metrics
Short interest
5.4%
Latest settlement · 3.9 days to cover
Days to cover
3.9d
Short-squeeze score
56 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$26.17M
Insider-sentiment score
18 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1568651 CUSIP 687793109 13F (30d) 434 filings 403 filers Visit website Investor relations